SHBG: the lab value that explains why your hormones look normal
Two women, the same total testosterone on the report, two completely different realities in the tissue. In between sits a protein from the liver that hardly anyone explains.
You are sitting at the kitchen table with a sheet of paper. Your name at the top, below it a column of values and a column of reference ranges. Nothing is printed in bold. Nothing has an asterisk. Everything is within range.
And still something is off. The hairs on your chin are new. Your cycle comes when it feels like it. Your skin behaves as it did at seventeen. Your energy lasts until four in the afternoon and then it is over.
Many women know this pattern. The report says fine, the body says something else, and nobody can explain both at the same time. This is not a problem of imagination. It is usually a problem of translation.
Because a hormone value in the blood tells you how much hormone is on the move. It does not tell you how much of it arrives. Between those two sentences sits a protein with an unwieldy name: sex hormone binding globulin, SHBG for short.
SHBG is not a side value. It is the translator between what is written in the blood and what arrives at the cell. And because the liver produces it under the influence of insulin, it says something along the way about metabolism that blood sugar and HbA1c often do not show yet.
That is why I measure SHBG alongside, before I tick off a hormone result as unremarkable. And that is why, with a low value, I look first at the liver, the insulin situation and the thyroid, before I talk about hormones.
One sentence up front: the gynaecological workup remains the foundation. It answers questions that no lab value can answer. The metabolic perspective comes on top of it, not in its place. That it is not routinely part of basic diagnostics has to do with the purpose of that diagnostic work and not with the care of those who carry it out.
What this article covers
- Why two identical values can mean two different people
- What SHBG is and how much hormone is really free
- What pulls the value down, insulin above all
- What pushes it up, oral estrogens above all
- Why a low value may be an early metabolic signal
- The free androgen index and its limits
- When and how SHBG is sensibly measured
- What actually moved in intervention studies
No value and no text replaces a medical examination. These red flags belong in medical hands promptly and not on a waiting list, no matter what your SHBG looks like:
- Bleeding after the menopause
- Very heavy bleeding or a suddenly changed bleeding pattern
- Lower abdominal pain with fever
- Acute, one sided lower abdominal pain
- Unintended weight loss
- Headache or visual disturbance together with milk discharge from the breast
- Rapidly progressing virilisation, meaning a deepening voice, strong facial hair growth, periods stopping within a few months
With acute, very severe abdominal pain, or with heavy bleeding accompanied by weakness, a racing heart or circulatory problems, please call the emergency number, 112 in Germany, and do not wait for an appointment.
Two of the conditions that appear further down as a cause of a high SHBG are also not something to sit out: overt thyroid overactivity and liver disease with impaired function belong in prompt medical assessment, regardless of what SHBG says about them.
And one more thing: if you are already taking a medication that appears in this article, meaning the pill, a thyroid preparation, metformin, an antiandrogen or a hormone therapy, then do not change anything about it because of a text on the internet. Every adjustment belongs in a medical conversation and needs medical supervision.
Every medicine named in this article is prescription only, meaning the pill with the active substance ethinylestradiol, thyroid preparations, metformin, antiandrogens and hormone therapies. Some of them are used for hormone and metabolic questions outside their marketing authorisation, which is called off label. Metformin, for example, is authorised in Germany for type 2 diabetes and not for polycystic ovary syndrome or insulin resistance. Off label means separate patient information, a particular duty of medical justification and, as a rule, no reimbursement by the statutory insurer. Benefits, risks, contraindications and interactions are weighed case by case by the prescribing physician. Nothing in this article amounts to a recommendation for or against any of these medicines.
These seven labels sit next to every study. Between an effect in cell culture and an effect in a thousand women lie worlds, and on the internet both regularly end up in the same pot.
Why two identical lab values can mean two different women
Picture two women, same age, same report. Both have the same total testosterone, somewhere in the upper half of the reference range, let us say. On paper they are twins.
One of them has no complaints at all. The other struggles with hair growth on her chin, with oily skin, with a cycle that keeps shifting. How can that be, when the number is the same?
Because the number measures the wrong thing. More precisely: it measures everything, and only a small part of it is interesting.
The image with the crates of bottles
I like this image better than the dimmer switch you often read about. Imagine your blood is a drinks store. The report says how many bottles are in the shop. That is total testosterone.
But most bottles are in crates, strapped down, on pallets. They are there, they count, they are not within reach for the moment. Only the few bottles standing loose on the shelf can be picked up and opened.
SHBG is the pallet. It packs testosterone and estradiol up and carries them through the blood. Packed hormone travels along without arriving. Only the free fraction can dock onto the receptor of a cell and set something off there.
And now back to the two women. One has a lot of SHBG. In her, almost all the bottles are in crates. The other has little SHBG. In her, a much larger share stands open on the shelf. Same total number, completely different availability.
A review from Vancouver gathered what SHBG actually does across different species. What was observed: SHBG transports androgens and estrogens in the blood and in doing so regulates how much of them reaches the target tissue, how quickly they are broken down and how they are distributed in the body. Production in the liver varies over a lifetime and is determined above all by metabolic and hormonal factors, with genetic differences between people on top.
What this means for you: SHBG is not a passive container. It has a say in how much hormone arrives at all. That is why the same total value may describe two different realities in two people.
Hammond, Biology of Reproduction 2011. PMID: 21613632 · DOI: 10.1095/biolreprod.111.092593 [Mechanism Review]The sentence you have probably already heard is: your values are normal. The more precise sentence is: your total values lie within the reference range, which on its own says little about the available amount.
That is not a criticism of anyone. It is a question that has to be asked from the report, and it is not always asked, because it is not part of basic diagnostics. You are allowed to ask it.
By the way, this is not only about testosterone. SHBG also binds estradiol, although with less force. That means the same arithmetic applies to the estrogen someone read out to you as unremarkable.
Which test makes sense when is covered in hormone testing in women. Here the takeaway is enough: SHBG is the value that makes the others readable in the first place.
And now you know why two identical numbers can tell two different stories.
What SHBG actually is and how much hormone is really free
A short inventory, so the word stops sounding like exam material.
SHBG is a protein. It is built in the liver and released into the blood. There it binds sex steroids, meaning testosterone, dihydrotestosterone and estradiol. It does not do this indiscriminately but with different force: it holds testosterone more tightly than estradiol.
Besides SHBG there is a second binding partner: albumin. It is the most common protein in the blood, an all rounder that binds almost everything a little. Albumin holds hormones considerably more loosely than SHBG. That is why hormone bound to albumin is often counted towards the so called bioavailable fraction.
Let us stay with the drinks store. SHBG is the strapped down pallets. Albumin is the crates standing open in the aisle, from which you can pull a bottle with some effort. And the small remainder really does stand free.
Why the number on paper is only the first step
- The liver builds SHBG. The production rate depends on the metabolic situation the liver cell is currently working in.
- SHBG goes into the blood and binds sex steroids. Testosterone more tightly, estradiol more loosely. Albumin binds in addition, but loosely.
- The lab measures the sum. The value total testosterone contains bound and free hormone in one number.
- Only unbound hormone reaches the receptor. That is the free hormone hypothesis, the load bearing model of laboratory medicine.
- From the total value, SHBG and albumin the free fraction can be estimated. Estimated, not measured. This difference becomes important in a moment.
The order of magnitude we are talking about here: only a very small percentage of the testosterone in the blood is actually unbound. By far the largest part hangs on SHBG or on albumin. Precisely for that reason a shift in the transport protein may change the free fraction strongly, without the total value moving noticeably.
The honest limitation that appears almost nowhere
Now comes the part most pages leave out, because it disturbs the neat explanation. The free hormone hypothesis is a model. Not a law of nature.
A team from Boston and Manchester recalculated the entire binding physiology of testosterone in Endocrine Reviews in 2017 and pulled together decades of published experimental data for it. What was observed: the assumptions of the common binding models about stoichiometry, binding dynamics and affinity are not supported by these data and are most likely inaccurate. At the same time the paper names the known problems of directly measuring free testosterone.
What this means for you: calculated values are estimates, not measurements. They are good for the direction, not for the second decimal place. Anyone who turns a formula into a diagnosis is overstretching it.
Goldman, Bhasin, Wu, Krishna, Matsumoto, Jasuja, Endocrine Reviews 2017. PMID: 28673039 · DOI: 10.1210/er.2017-00025 [Mechanism Review]Why am I telling you this while at the same time making a case for the value? Because the two belong together. A value whose limits you know is worth more to you than a value you take for a final verdict.
The most common disappointment with lab values arises when we take them for photographs. They are more like weather reports. They describe a situation with a certain blur, at a certain point in time, with a certain method.
SHBG is a good weather report. It is more stable than the steroid hormones themselves and it points in a direction. What it is not: a verdict about you.
A side note that shows how young this field still is: according to the paper from Vancouver, SHBG also accumulates outside the vessels, where it may unfold effects of its own (Hammond 2011, PMID: 21613632). Basic research, not an instruction for action.
And now you know why I am enthusiastic and cautious about this value at the same time.
What pulls SHBG down, insulin above all
If your SHBG is low, the first sensible question is not how to get it up. It is: why is it down?
And there is one factor that towers above all the others. Insulin.
This is not a side note from functional medicine. It is one of the few chains in this field that runs cleanly through three levels of evidence. Cell culture, animal model, human. I will show you all three, and with each one I will tell you how far it carries.
Level one: the liver cell in the test tube
A research group at the Madigan Army Medical Center in Tacoma incubated human liver cancer cells of the HepG2 line for 72 hours with insulin, prolactin, estradiol, thyroxine and testosterone, and then measured how much SHBG these cells produce. What was observed: insulin lowered production from 65.0 plus minus 0.6 to 46.8 plus minus 1.1 nanomol per million cells, prolactin to a practically identical value, each with a p below 0.01. Insulin also braked the increase that estradiol and thyroxine otherwise triggered. Testosterone, estradiol and thyroxine raised production.
What this means for you: the effect of insulin on SHBG can be seen directly at the liver cell. That is a strong mechanistic argument. It is not yet proof in humans. Cell culture remains cell culture.
Plymate, Matej, Jones, Friedl, Journal of Clinical Endocrinology and Metabolism 1988. PMID: 2842359 · DOI: 10.1210/jcem-67-3-460 [In vitro]Level two: why it happens
Almost twenty years later the same line of research found the switch that gets turned. And the answer is surprisingly precise.
A group at the University of British Columbia built transgenic mice carrying the human SHBG gene, and alongside that treated HepG2 cells with glucose and fructose. What was observed: both sugars lowered SHBG production, and not directly but by a detour. They ramped up new fat production in the liver cell. In the process the transcription factor HNF-4alpha dropped, which normally gives the start signal at the SHBG gene. Another factor took its place, and the reading of the gene was throttled. When new fat production was blocked, the SHBG drop did not occur.
What this means for you: in this model it appears not to be sugar as such that lowers SHBG, but the new fat production in the liver that it sets off. That may explain why SHBG reacts so sensitively to a fatty liver. Important and honest: mouse and cell culture, not human.
Selva, Hogeveen, Innis, Hammond, Journal of Clinical Investigation 2007. PMID: 17992261 · DOI: 10.1172/JCI32249 [In vivo, mouse] [In vitro]How the liver ends up in that state is covered in sugar, fructose and the liver. One sentence is enough here: the liver is the building site of SHBG.
Level three: the human
Now comes the study I consider the most elegant in this whole field. It is tiny, it is old, it has no control group, and it still goes at exactly the question at hand.
A group at the Medical College of Virginia in Richmond studied six women with polycystic ovary syndrome and overweight. First the hormone production of the ovaries was shut down with medication, so that the sex hormones dropped out as a confounder. Then the women received a drug for ten days that lowers insulin secretion. What was observed: although testosterone, androstenedione, estrone, estradiol and progesterone had fallen massively, SHBG stayed unchanged at around 18 nmol/l. Only when insulin fell, namely from 262 plus minus 55 to 102 plus minus 33 nanomol per minute and litre in the glucose tolerance test, did SHBG rise within ten days by 32 percent, from 17.8 plus minus 2.6 to 23.5 plus minus 2.0 nmol/l, with a p below 0.003. The testosterone not bound to SHBG fell by 43 percent as a result. What honesty requires, and what the same abstract states: under the same drug, glucose tolerance deteriorated.
About the drug, so that no wrong impression arises here: the active substance used was diazoxide. It is prescription only. It is authorised for a quite different situation, namely low blood sugar caused by pathologically raised insulin secretion. For the question in this study it was used outside its authorisation, that is, off label. It can raise blood sugar, retain fluid in the tissue and affect the circulation, and increased body hair growth is also described. I deliberately say nothing here about doses. In this work the drug served as a tool to answer a question about mechanism, and explicitly not as a treatment.
What this means for you: in this investigation insulin appeared to act directly on SHBG and not by the detour of the sex hormones, and that may explain why a low SHBG so often coincides with a state of excess insulin. The limitation belongs next to it: six women, ten days, no control group, a drug with a harm of its own that is not used this way today. This is a pointer to a mechanism and explicitly not a treatment recommendation.
Nestler, Powers, Matt, Steingold, Plymate, Rittmaster, Clore, Blackard, Journal of Clinical Endocrinology and Metabolism 1991. PMID: 1898744 · DOI: 10.1210/jcem-72-1-83 [human intervention study, no control group, n=6]And now the finding that keeps the story from becoming too smooth. The same group carried out the same intervention in five slim, healthy women with a regular menstrual cycle.
In healthy slim women nothing happened
Insulin fell clearly here too, from 108.0 plus minus 28.2 to 49.3 plus minus 5.2 nanomol per minute and litre. SHBG did not move, it was 79.7 plus minus 16.6 compared with 70.2 plus minus 12.6 nmol/l in the control phase, without statistical significance. Total testosterone also stayed where it was.
So the lever takes hold where too much insulin is on the move. Someone without a state of excess does not raise SHBG by pushing insulin down even further. This finding protects against the widespread exaggeration that anyone can drive their SHBG value up at will.
Nestler, Singh, Matt, Clore, Blackard, American Journal of Obstetrics and Gynecology 1990. PMID: 2220936 · DOI: 10.1016/0002-9378(90)90698-7 [human intervention study, n=5]
What else pushes it down
Insulin is the strongest single factor, but not the only one. The following points appear in every endocrinology textbook and in every German lab catalogue. For some of them I found no primary study with robust numbers in this research, and therefore I name them without numbers and mark them as textbook knowledge.
What lowers the value and what raises it
Downwards
- High insulin and insulin resistance, best documented
- Overweight, especially around the abdomen
- Fatty liver
- Underactive thyroid
- Androgens from outside, including anabolic substances
- Growth hormone, textbook knowledge without its own numbers here
- Corticosteroid preparations, textbook knowledge without its own numbers here
- Certain genetic variants
Upwards
- Oral estrogens, above all the combined pill
- Pregnancy
- Overactive thyroid
- Liver disease with impaired function
- Higher age, particularly marked in men
- Very low body weight and prolonged fasting, textbook knowledge without its own numbers here
- Certain genetic variants
This list is a map, not a diagnosis. Several points may apply at once and cancel each other out. Precisely for that reason an SHBG value is never read in isolation, but together with the thyroid, liver values, blood sugar status and the question of which medications are currently being taken.
A low SHBG is not a defect in the transport system. It is usually a sensible reaction of the liver to a situation it currently finds itself in. The body rarely does nonsense. It does adaptation.
That changes the question. Not: how do I repair this value? But: what is my liver currently reacting to, and is that situation something that can be changed?
What insulin resistance is and what it does to the menstrual cycle is covered in insulin resistance and hormones in women. Here I stay with the one question: what does it do to the transport protein.
And now you know why, with a low SHBG, I talk about the liver and blood sugar first and not about hormones.
What pushes SHBG up, estrogens and the pill above all
There is one situation in which an SHBG value is regularly misunderstood. And in both directions.
The value is high, very high even, and someone reads that as good news. Or the value is high and someone reads it as illness. Both may be off the mark when one decisive circumstance is not on the list: the use of an oral estrogen.
The pill does not change things a little, it changes the order of magnitude
A Dutch research group pooled 42 studies with 1495 healthy women between 18 and 40 years of age, all with an experimental design. What was observed: under combined oral contraception total testosterone fell on average by 0.49 nmol/l, free testosterone fell on average by 61 percent, and SHBG rose on average by 99.08 nmol/l with a confidence interval from 86.43 to 111.73. Preparations with 20 to 25 micrograms of ethinylestradiol influenced testosterone about as strongly as those with 30 to 35 micrograms. On SHBG, by contrast, both the lower estrogen doses and second generation progestins had a smaller effect. The authors state that the clinical significance of the lowered androgens is still open.
What this means for you: on the pill SHBG is not a little higher. It sits in a different world, and free testosterone falls more than twice as strongly as the total value. A result taken on the pill primarily describes the pill.
Zimmerman, Eijkemans, Coelingh Bennink, Blankenstein, Fauser, Human Reproduction Update 2014. PMID: 24082040 · DOI: 10.1093/humupd/dmt038 [Meta-analysis, k=42, n=1495]Why does ethinylestradiol do this? Because it runs through the liver. A hormone that is swallowed passes the liver before it reaches the rest of the circulation. And there it meets exactly the cells that build SHBG. They respond by ramping production up.
An Italian review from Catania and Catanzaro gathered what oral contraceptives do to the transport proteins of the liver and to the thyroid axis. What was observed: the estrogen component raises the formation of several liver proteins at once, among them thyroxine binding globulin, SHBG and clotting factors. The progestin component modulates these estrogen dependent effects, above all through its antiandrogenic direction of action.
What this means for you: under oral estrogens the liver ramps up a whole group of proteins. That is why thyroid values also have to be read differently on the pill, and that is why a rise in SHBG under oral estrogens no longer says anything about your insulin situation.
Torre, Calogero, Condorelli, Cannarella, Aversa, La Vignera, Journal of Endocrinological Investigation 2020. PMID: 32219692 · DOI: 10.1007/s40618-020-01230-8 [Mechanism Review]No recommendation to stop the pill follows from these numbers. Neither because of the SHBG value nor because of how informative a lab result is.
Whether a pill suits someone and whether it is paused are medical decisions. Contraceptive reliability, bleeding intensity, skin and sometimes the management of endometriosis all hang on it. What happens in the post pill phase is covered in stopping the pill, with the same note about medical supervision.
The thyroid, the second big lever upwards
SHBG responds to thyroid hormone. And so clearly that an undetected thyroid problem may throw off every androgen calculation.
A group at Semmelweis University in Budapest measured SHBG in people with different thyroid states and compared them with controls. What was observed: in overt hyperthyroidism SHBG was 141.6 plus minus 37.6 nmol/l compared with 48.3 plus minus 16.2 nmol/l in the controls. In hypothyroidism it was 24.9 plus minus 14.8 nmol/l. In subclinical hyperthyroidism the mean of 47.4 plus minus 16.8 matched that of the controls, and in subclinical hypothyroidism it was 33.6 plus minus 6.1, close to the lower limit.
What this means for you: between underactive and overactive thyroid there is almost a sixfold difference here. Anyone interpreting SHBG has to know the thyroid status. Limitation: a small, older paper using the measurement methods of 1990.
Földes, Banos, Lakatos, Tarjan, Orvosi Hetilap 1990, Hungarian with English abstract. PMID: 2392320 [Cohort]Which thyroid values actually count and which can be skipped is covered in thyroid blood values: which ones really count. And how the thyroid and the menstrual cycle hang together is in the thyroid and female hormones.
Age, pregnancy, liver
In men SHBG rises over the years. That has a practical consequence which is rarely spelled out.
At the National Institute on Aging, stored blood samples from 890 men of the Baltimore Longitudinal Study on Aging were analysed with a mixed statistical model over time. What was observed: testosterone and the free testosterone index fell linearly and independently of each other with age, on average by minus 0.124 nmol/l per year and minus 0.0049 nanomol testosterone per nanomol SHBG per year respectively. The share with hypogonadal values rose to around 20 percent beyond 60, 30 percent beyond 70 and 50 percent beyond 80 years of age, and by the free index even higher.
What this means for you: in men the free fraction falls more strongly with age than the total value, because SHBG rises at the same time. That is why a total testosterone within the reference range looks different in a 70 year old than in a 30 year old.
Harman, Metter, Tobin, Pearson, Blackman, Journal of Clinical Endocrinology and Metabolism 2001. PMID: 11158037 · DOI: 10.1210/jcem.86.2.7219 [Cohort, n=890]In pregnancy SHBG rises strongly. That is physiological and not a red flag. It does have one methodological consequence that matters in a moment: the calculation procedures for free testosterone do not apply in pregnancy.
A high SHBG value is rarely the actual issue. It is almost always a pointer to something else: a medication, a thyroid state, a pregnancy, something going on in the liver, an age in life.
That is why the right reaction to a high value is not worry but a question: which of all this applies to me? In the vast majority of cases the answer is mundane and already written on the medication list.
And now you know why the first question with a striking SHBG is what is currently being taken.
Why a low SHBG may be an early pointer to the metabolic situation
Now comes the part that turns SHBG from a side value into something interesting. And the part where I have to be most careful, so that an association does not become a prophecy.
Blood sugar is a late value. It becomes noticeable when the pancreas can no longer compensate. Years before that a quiet phase runs, in which the body pushes back with more and more insulin and sugar therefore still looks normal.
And SHBG? It responds to exactly that insulin. Not to the sugar. That makes it an indirect window into a phase that is otherwise hard to see.
A group at the Brigham and Women's Hospital and at Harvard Medical School pooled 43 prospective and cross sectional studies with 6974 women and 6427 men. What was observed: in the prospective studies, women with SHBG above 60 nmol/l had an 80 percent lower risk of type 2 diabetes compared with women at 60 nmol/l or below, with a relative risk of 0.20 and a confidence interval from 0.12 to 0.30. In men the comparison used a threshold of 28.3 nmol/l and gave a 52 percent lower risk. The difference between the sexes was statistically significant. Testosterone behaved in the opposite direction: in men, higher values went together with lower risk. In women the reverse direction was suggested, without the difference reaching statistical significance in the prospective studies.
What this means for you: a low SHBG is a clearer signal in women than in men. And the same testosterone value can mean something different in the two sexes. These are observational data, not proof of cause and effect.
Ding, Song, Malik, Liu, JAMA 2006. PMID: 16537739 · DOI: 10.1001/jama.295.11.1288 [Meta-analysis, k=43]The obvious objection: perhaps the low SHBG is only a side effect. People with more abdominal fat often have more insulin, more insulin may lower SHBG, and the same people more often develop diabetes. The value would then be a spectator and not a player.
The same research group attacked this objection three years later with a clever trick.
In the Women's Health Study, 359 postmenopausal women with newly occurring type 2 diabetes were compared with 359 controls, all without hormone therapy. In addition two gene variants that influence the SHBG level were typed and used for a so called Mendelian randomisation. The idea behind it: genes are distributed at random at conception and cannot be shifted by lifestyle. What was observed: compared with the lowest SHBG quartile, the odds ratios in the higher quartiles lay between 0.16 and 0.04 in women. In a separate cohort of men, the Physicians' Health Study II with 170 cases and 170 controls, the picture repeated itself: the highest SHBG quartile versus the lowest was 0.10. Carriers of the variant rs6259 had 10 percent higher and carriers of rs6257 10 percent lower SHBG levels, each with the matching direction of risk.
What this means for you: the association has a genetic anchor, which argues for a causal contribution. The honesty alongside it: the effect estimates are extremely large, the case numbers small, and such numbers are upper bounds by experience.
Ding, Song, Manson, Hunter, Lee, Rifai, Buring, Gaziano, Liu, New England Journal of Medicine 2009. PMID: 19657112 · DOI: 10.1056/NEJMoa0804381 [Cohort, case control]A lab value is not a fate. And an association in a cohort is not a diagnosis for the individual person. What becomes visible as a probability in a group of a thousand people still says nothing about you alone.
What the value reflects in large groups
A Chinese research group analysed the baseline data of 1000 women with polycystic ovary syndrome from a registered trial and set SHBG against body measurements, sugar, lipid, liver and kidney values. What was observed: women with lower SHBG had a higher BMI, larger waist circumference, higher insulin and HOMA-IR, higher blood pressure, higher triglycerides, ApoB, LDL, AST, ALT and urea nitrogen as well as lower HDL. In the regression analysis SHBG was a protective predictor for metabolic syndrome, the area under the ROC curve was 0.732. With the glucose parameters, by contrast, there was no association.
What this means for you: SHBG here reflects the liver and lipid situation rather than the current blood sugar. That makes it an early signal. A ROC area of 0.73 is usable, but it is not a screening test.
Luo, Yang, Cai, Chang, Ma, Peng, Wu, International Journal of Endocrinology 2020. PMID: 33101409 · DOI: 10.1155/2020/7580218 [Cohort, n=1000]A group from Honolulu and Cooperstown pooled 16 observational studies with 13,721 men and 5,840 women. What was observed: men with fatty liver had a lower total testosterone, with a mean difference of minus 2.78 nmol/l. In women a higher testosterone went together with a higher probability of fatty liver. SHBG was lower with fatty liver in both sexes, and this inverse association was more pronounced in women.
What this means for you: the liver is the place where SHBG is made. If it becomes fatty, the value may drop. Limitation: the pooled testosterone value in men has an I squared of 99 percent, so it shows a direction and not precision.
Jaruvongvanich, Sanguankeo, Riangwiwat, Upala, Annals of Hepatology 2017. PMID: 28425408 [Meta-analysis, k=16]Many women hear in this section for the first time that their hormone problem and their metabolism might be the same story. That can feel heavy at first, along the lines of: now I have two problems instead of one.
I read it the other way round. If both hang on one thread, there is one shared point of leverage instead of two separate building sites. That is good news, not bad.
Where that point of leverage lies in practice is covered in insulin resistance and weight loss and in silent inflammation and weight.
One more thing, explicitly: SHBG is not a diagnostic criterion for polycystic ovary syndrome. The diagnosis follows its own internationally agreed criteria and belongs in medical hands. More on that in understanding polycystic ovary syndrome.
And now you know why I consider this value a good early signal and still send nobody home with it alone.
Free testosterone, the free androgen index and the limits of the calculation
If you search the internet for free testosterone, you land on a calculator within seconds. Number in, number out, done. I want to explain why I am not giving you a formula here, and why that is not paternalism.
There are three routes, and they are not equally good
The first route is measurement in the lab via an elaborate separation procedure, equilibrium dialysis. That is the reference method. It is expensive and rarely done.
The second route is calculation from total testosterone, SHBG and albumin via a binding model. Online calculators and lab software exist for this.
The third route is the free androgen index, FAI for short. It simply puts total testosterone in relation to SHBG. It is no more calculation than that, and precisely there lies its problem: albumin does not appear in it.
A group at Ghent University Hospital compared several estimation procedures for free testosterone against the reference method equilibrium dialysis, in a large number of blood samples with very different SHBG conditions, from very low to extremely high. What was observed: the free testosterone calculated from total testosterone and measured SHBG was nearly identical to the dialysis result under all conditions examined, with a single exception, namely pregnancy. The direct analogue immunoassay, by contrast, delivered only a fraction of the reference values, and this fraction shifted with the SHBG level. The ratio of FAI to the reference value also varied with the SHBG level.
What this means for you: the free androgen index is a rough orientation. It fails where things get interesting, namely at very high and very low SHBG. The calculated free testosterone is more robust, but not in pregnancy either.
Vermeulen, Verdonck, Kaufman, Journal of Clinical Endocrinology and Metabolism 1999. PMID: 10523012 · DOI: 10.1210/jcem.84.10.6079 [Systematic Review]What the guidelines say about it
Here is the point where my view and the state of the guidelines explicitly coincide. That matters to me, because with integrative medicine the suspicion of a fringe opinion is quickly in the room.
The update of the international PCOS guideline was produced by the Australian NHMRC in partnership with ASRM, the Endocrine Society, ESHRE and ESE, with 58 prioritised questions, 52 systematic reviews and 254 recommendations. In substance it states: to assess biochemical hyperandrogenism, total and free testosterone should be used, with free testosterone able to be estimated via the calculated free androgen index. For total testosterone, high accuracy LC-MS/MS methods should be used. Under combined oral contraception, biochemical hyperandrogenism is hardly reliable to assess. Insulin resistance is pathophysiologically relevant, but the clinically available insulin assays have limited relevance and are not recommended for routine care.
What this means for you: in this guideline SHBG is a component of a calculation and not a target value of its own. The document contains no standalone SHBG recommendation. That belongs here, even though it runs counter to my enthusiasm for the value.
Teede, Tay, Laven, Dokras, Moran, Piltonen and others, Human Reproduction 2023. PMID: 37580037 · DOI: 10.1093/humrep/dead156 [Guideline] [Consensus Guideline]The Endocrine Society updated its guideline on testosterone therapy in hypogonadism using GRADE methodology. In substance it states: initial diagnostics use a fasting total testosterone in the morning with an accurate method, confirmed by a second measurement. If the total value lies near the lower limit of normal or a condition exists that alters SHBG, free testosterone should be determined by equilibrium dialysis or estimated with an accurate formula.
What this means for you: even a very cautious professional society says explicitly that the total value alone is no longer informative as soon as SHBG falls outside the usual range. That is exactly the core message of this article, and it does not contradict routine care.
Bhasin, Brito, Cunningham, Hayes, Hodis, Matsumoto, Snyder, Swerdloff, Wu, Yialamas, Journal of Clinical Endocrinology and Metabolism 2018. PMID: 29562364 · DOI: 10.1210/jc.2018-00229 [Guideline] [Consensus Guideline]The FAI is permitted and still the cruder value
The PCOS guideline explicitly permits the calculated free androgen index. The method comparison from Ghent concludes that the FAI is not a reliable index of bioavailable testosterone, because its ratio to the reference value varies with the SHBG level.
Both statements hold. The guideline decides on practicability at scale, the methods paper on accuracy at the edges. For you that means: the FAI works as an orientation as long as your SHBG lies in the middle range. At the edges it becomes unreliable. That judgement is made by the physician, not by a calculator on the internet.
Why there is no formula here
I could write a formula out for you now. I am not doing it, for three reasons.
First, a number without context changes nothing about your situation but may create fear. Second, the results of different calculators and lab methods are not readily comparable. And third: no treatment follows from a calculated value. A conversation follows.
The widespread idea is: if I only calculate the right number, I understand my body. The more precise idea is: a number makes a question sharper.
That is a downgrade for the number and an upgrade for you. Because you can ask the question, and the answer arises in conversation with someone who has your whole set of results in front of them.
If you have a testosterone value in front of you and want to place it, the detailed reading guide is in understanding testosterone values. That article covers time of day, assay and repeat measurement.
And now you know why the quick calculation on the internet is not the answer you are looking for.
The practical part: when and how SHBG is sensibly measured
So far there has been a lot of physiology. Now the part you can take with you into your next consultation.
When the value belongs in the panel
Situations in which SHBG makes the other values readable in the first place
- Complaints and total values do not fit together. This is the most common situation. The report says unremarkable, the body says something else.
- Signs of an androgen effect. Increased hair growth on the chin, upper lip or abdomen, stubborn acne around the chin and jaw, hair loss at the crown.
- Before a testosterone value is interpreted. In women as in men. Without SHBG the total value is only half the information.
- When an insulin situation is suspected. Weight around the middle, afternoon cravings, dark skin discolouration in skin folds, diabetes in the family.
- With an unclear cycle disturbance. As additional information alongside the gynaecological workup, not instead of it.
- When the thyroid situation is unclear. SHBG can show whether thyroid hormone is arriving at the liver cell.
And what SHBG does not do: androgenic signs can have other causes too. Among them are a congenital disorder of the adrenal cortex, non classic congenital adrenal hyperplasia, and more rarely a Cushing syndrome. Both are looked for with values of their own, for adrenal hyperplasia with 17-hydroxyprogesterone for example, and not with SHBG. That belongs in the medical work-up, before everything is attributed to the insulin situation.
Cycle day, time of day, fasting
Here I want to be more cautious than the internet usually is on this point.
SHBG is considerably more stable across the menstrual cycle than estradiol and progesterone, which can multiply within a few days. I did not find a good, clearly citable paper in this research showing a relevant SHBG fluctuation across the cycle. So I give you no number and no SHBG specific ideal day.
In practice that means: the cycle day of the blood draw follows the hormones measured alongside. For progesterone that is the second half of the cycle, for estradiol it depends on the question. SHBG simply rides along.
On fasting, the same principle. For SHBG itself I found no robust primary source. Blood is drawn fasting because of the other values: guidelines place testosterone in a fasting morning sample, and glucose and insulin need it anyway.
On the pill: one value, two different questions
What an SHBG value still says on the pill and what it does not
- What it no longer says
- It no longer describes your own insulin and liver situation. The meta-analysis showed a mean rise of 99.08 nmol/l, which overlays everything else (Zimmerman 2014, PMID: 24082040).
- What follows from that for androgen values
- Biochemical hyperandrogenism is hardly reliable to assess under combined oral contraception. That is stated in the international PCOS guideline (Teede 2023, PMID: 37580037).
- What it still shows
- That your liver responds to the estrogen. An SHBG that does not rise on the pill is an observation in its own right and belongs in a medical assessment.
- When an androgen assessment is strictly necessary
- For that case the guideline names a pill pause of at least three months with contraception otherwise secured. That is a medical decision in a concrete situation.
No recommendation follows from any of these points to stop, pause or reduce a preparation on your own. That is decided in conversation with the physician who issued the prescription. Whether SHBG settles permanently at a different level after stopping is not cleanly established.
What a low value means in a woman and what it means in a man
The same low value, two different questions behind it
In a woman
- A larger share of the testosterone present is travelling around unbound
- A testosterone value in the middle of the reference range may still go together with androgenic signs
- The metabolic link is statistically stronger than in men
- The next sensible questions concern the insulin situation, the liver and the thyroid
In a man
- Total testosterone underestimates the free fraction
- The value looks lower than the effect at the tissue would suggest
- The metabolic link exists here too, but is weaker
- The guideline explicitly asks here for free testosterone to be measured or calculated
What stays the same in both columns: SHBG is not a value that gets treated. It is a value that shows which question comes next.
Why this article contains no reference table
That is a deliberate decision, and you should know the reason.
SHBG is measured with different immunoassays that are not standardised against each other. Every lab sets its reference range using its own method and its own comparison group. On top of that, the value diverges widely by sex, age, cycle phase, pregnancy and hormone use.
A table on the internet would therefore fake a universally valid boundary. That boundary does not exist. What applies is the range printed next to the value on your own report, and the most informative thing is the trend in the same lab.
I know the disappointment at this point. You wanted a number from which things become critical, and instead you get an explanation of why that number does not exist.
But that is exactly the more useful information. Anyone who knows that reference ranges depend on the method stops measuring themselves against someone else's table. And starts looking at their own trend.
And now you know which question you can ask at your next appointment: does my total value fit my SHBG, and what does that mean for the free fraction?
What actually shifted SHBG in studies
Finally the most honest part. Not what could theoretically move something, but what actually shifted numbers in controlled investigations. With effect sizes, and with what moved nothing.
An American and Canadian research group ran a single blind randomised trial over twelve months between 2005 and 2009, with postmenopausal women aged 50 to 75, a BMI above 25 and less than 100 minutes of exercise per week. Four groups: reduced calorie diet with 118 women, endurance training with 117, both combined with 117, control with 87. Mean age 58 years, mean BMI 30.9. What was observed: SHBG rose compared with the control by 22.4 percent on diet and by 25.8 percent on diet plus exercise, both with a p below 0.001. For exercise alone, no significant SHBG increase is reported in the abstract. Free estradiol fell by 21.4 and 26.0 percent respectively, free testosterone by 10.0 and 15.6 percent. The greater the weight loss, the stronger the effects.
What this means for you: weight loss shifted SHBG by a good fifth in one year. For exercise alone, no separate SHBG increase is reported in this analysis. That does not argue against exercise, it only shows that SHBG here moved above all with the weight loss. And the limitation belongs with it: these were postmenopausal women with overweight, not all people.
Campbell, Foster-Schubert, Alfano, Wang and others, Journal of Clinical Oncology 2012. PMID: 22614972 · DOI: 10.1200/JCO.2011.37.9792 [RCT, n=439]At the University of Kansas Medical Center, 24 evaluable postmenopausal women with overweight and elevated breast cancer risk went through a six month behaviour based weight reduction programme, with a mean starting BMI of 34.2. What was observed: the median weight loss among participants was 11 percent. SHBG rose, bioavailable estradiol and bioavailable testosterone fell, as did insulin and CRP. In the subgroup analysis the markers were substantially changed essentially only in the women who had lost more than 10 percent.
What this means for you: there appears to be a threshold. Small changes in weight barely moved the markers in this investigation. Limitation: 24 women, no control group, feasibility study. That is a signal, not proof.
Fabian, Kimler, Donnelly, Sullivan and others, Breast Cancer Research and Treatment 2013. PMID: 24141897 · DOI: 10.1007/s10549-013-2730-8 [Cohort, n=24]At Linköping University in Sweden a randomised study on resistance training in postmenopausal women with hot flushes was carried out. In the substudy, 26 women were in a 15 week resistance training programme and 29 in a sedentary control group, with blood draws at week 0 and 15. What was observed: comparing the change values, median testosterone and SHBG rose significantly in the training group compared with the control. The paper was primarily about adipokines, however.
What this means for you: resistance training might move SHBG, even without weight loss. The limitations belong next to it: secondary endpoint, small group, no dietary control. The authors themselves name larger studies as necessary.
Ward, Nilsson, Hammar, Lindh-Astrand and others, Scientific Reports 2020. PMID: 33199796 · DOI: 10.1038/s41598-020-76901-w [RCT, n=55]What cannot be shifted
And now the part that protects against self reproach. Part of your SHBG value is predisposition.
An international consortium around Coviello examined the SHBG level of 21,791 people from ten epidemiological studies genome wide and checked the results in a further 7,046 people from six studies. What was observed: twelve genomic regions were linked to the SHBG level, most strongly the SHBG gene locus itself on chromosome 17. Further regions lay, of all places, at genes of liver metabolism and of fat and carbohydrate metabolism. In an independent sample all the variants found together explained around 15.6 percent of the genetic variation in men and around 8.4 percent in women.
What this means for you: part of your value is something you brought with you. And the genes found lie in liver and metabolic pathways, which explains why SHBG fits the metabolic situation so well and why two people with the same lifestyle may have different values.
Coviello, Haring, Wellons, Vaidya and others, PLoS Genetics 2012. PMID: 22829776 · DOI: 10.1371/journal.pgen.1002805 [Cohort, GWAS, n=21,791]The same gene locus was also found in 3,495 Chinese men (Chen 2013, PMID: 24049095 · DOI: 10.1136/jmedgenet-2013-101705) [Cohort, GWAS].
And where does the environment come in?
Now comes the section I have to explain most often in my practice. Because an idea circulates on the internet that sounds logical and that the data do not support.
The idea goes like this: xenoestrogens, meaning hormone like environmental substances, displace your own hormones from the transport protein and thereby set them free. Sounds plausible. It was investigated. The available data do not support it that way.
A group at King's College London tested whether environmental estrogens can displace labelled estradiol and dihydrotestosterone from binding proteins for sex steroids. Human plasma, fish plasma and, for comparison, the rat protein alpha fetoprotein were examined. Among the substances tested were bisphenol A, nonylphenol, octylphenol, several phthalates, DDT breakdown products, diethylstilbestrol and the plant compounds coumestrol, daidzein and genistein. What was observed: at the rat protein only two substances competed appreciably, and only at roughly a hundredfold higher concentration than estradiol, meaning a relative binding strength of around one percent, while all the others were far below 0.1 percent. In human plasma and in fish plasma the picture was similar, and there only a few substances displaced the natural ligand at all, at concentrations far more than a thousandfold higher. The authors concluded that environmental estrogens probably do not exert their effects by displacing the body's own steroids from the plasma binding proteins, except at very high concentrations.
What this means for you: on the basis of this laboratory work, there is little to suggest that xenoestrogens displace your hormones from the transport protein to any meaningful degree. If environmental substances act on SHBG, then on current data it is more likely to be indirect, via the liver and the insulin situation. That indirect route is not documented either, it is a working hypothesis. And this is a pure laboratory experiment.
Milligan, Khan, Nash, General and Comparative Endocrinology 1998. PMID: 9748407 · DOI: 10.1006/gcen.1998.7146 [In vitro]A group at the Hospices Civils de Lyon gave male mice purified human SHBG into the vein, so that levels lay within the range possible in humans, and afterwards administered radioactively labelled bisphenol A or estradiol by gavage. What was observed: the binding strength of labelled bisphenol A to human SHBG was far below that of labelled estradiol. Circulating SHBG slowed clearance from the blood in a dose dependent way, and mice with SHBG had less accumulation in the testis 24 and 48 hours after administration.
What this means for you: SHBG binds bisphenol A, but weakly. The paper suggests rather that a higher level might slow distribution into tissue. A mouse experiment with injected human protein. Hypothesis, not fact.
Bendridi, Mappus, Grenot, Lejeune, Cuilleron, Pugeat, Steroids 2002. PMID: 11996937 · DOI: 10.1016/s0039-128x(02)00014-4 [In vivo, mouse]Why I go into this at such length, although it runs counter to my own direction of enquiry: because in consultations I ask about mould, endocrine disruptors and heavy metals, and because that question is only worth something if it is asked in the right place. Not at the transport protein, but rather where the available data point: liver and insulin situation. Silent inflammation I add as a working hypothesis, for SHBG that route is not documented.
It does not follow from this that every hormonal disturbance has an environmental cause. The vast majority of shifts in SHBG are explained by weight, insulin status, liver, thyroid, medications, age and predisposition. The environmental question comes in when these explanations are not enough.
Where endocrine disruptors actually occur in everyday life and what is documented about them is covered in xenoestrogens and endocrine disruptors in everyday life. And how the liver breaks estrogen down is in lowering estrogen naturally: how the liver breaks estrogen down.
A word against the avoidance spiral
I have seen what happens when environmental topics are read without a brake. A sensible question turns into constant monitoring. Caution turns into control. Control turns into an everyday life that keeps narrowing, in which more and more foods, products and situations drop away.
That is not a good path. Chronic stress and heavily restricted eating are themselves strong influences on exactly this axis. When the preoccupation with values and avoidance becomes narrow, that is a topic in its own right. Understanding eating disorders: body and mind describes where that line runs.
My rule of thumb for environmental topics: change the three things that are biggest and easiest in your own everyday life, and then stop searching. The rest is a matter for an examination, not for research on the internet.
The widespread thought is: if I cannot change my value, the measurement was pointless. I see it differently.
The usefulness of SHBG does not lie in its being movable. It lies in making other values readable and in raising a question that otherwise does not get asked. A value that produces a better question has done its job.
And now you know what actually moved in studies, and what is predisposition.
Common questions about SHBG
What is SHBG in simple terms?
SHBG stands for sex hormone binding globulin. It is a protein that your liver releases into the blood, where it binds testosterone and estradiol. Bound hormone travels along without arriving. Only the unbound fraction can dock onto the receptor of a cell. So SHBG co-determines how much of the hormone printed on your report can become active at all. A review therefore describes SHBG not as a passive container but as a regulator of bioavailability (Hammond 2011, DOI: 10.1095/biolreprod.111.092593).
What does a low SHBG mean in a woman?
Two things at once. First: from a given total testosterone, a larger share is travelling around unbound. A testosterone value sitting in the middle of the reference range may still go together with androgenic signs. Second: a low SHBG can be a pointer to the metabolic situation, because the liver appears to throttle production above all under high insulin. The human data on this are small, the mechanism has been shown in cells and in the animal model. In a meta-analysis of 43 studies, women with SHBG above 60 nmol/l had an 80 percent lower diabetes risk than women at 60 nmol/l or below (Ding 2006, DOI: 10.1001/jama.295.11.1288). That is a group finding and not a personal prognosis. What follows from it belongs in a conversation with a physician.
What does a low SHBG mean in a man?
In men, low SHBG often means that total testosterone underestimates the free fraction. The value then looks lower than the effect at the tissue would suggest. The metabolic link applies here too, although more weakly than in women: in the same meta-analysis the advantage of a higher SHBG was 52 percent in men compared with 80 percent in women (Ding 2006). This is exactly why the Endocrine Society asks for free testosterone to be measured or calculated when SHBG is altered, instead of relying on the total value (Bhasin 2018, DOI: 10.1210/jc.2018-00229).
Which symptoms can accompany a low SHBG?
SHBG produces no symptoms of its own. What causes complaints is the combination of free hormone and the metabolic situation behind it. In women with polycystic ovary syndrome, lower SHBG values went together with less favourable blood pressure, lipid and liver values in one large analysis, but not with the blood sugar values (Luo 2020, DOI: 10.1155/2020/7580218). That describes frequencies in a group. It says nothing about what is going on in your case. That attribution belongs in a consultation and not in a symptom list on the internet.
What can be done when SHBG is low?
The first question is not how the value goes up, but why it is down. In studies, three things above all have proved movable: weight and the insulin situation, the state of the liver and thyroid function. In a one year randomised trial in postmenopausal women, SHBG rose by 22.4 percent on a reduced calorie diet and by 25.8 percent on diet plus exercise compared with the control group, while for exercise alone no separate SHBG increase is reported in this analysis (Campbell 2012, DOI: 10.1200/JCO.2011.37.9792). That does not mean exercise achieves nothing, only that SHBG in this study moved above all with the weight loss. Whether and which of this fits your case is a medical decision. SHBG is not a target value that gets treated.
What does a raised SHBG mean?
A high SHBG binds more hormone and leaves less free. Common reasons are oral estrogens, above all the combined pill, an overactive thyroid, pregnancy, liver disease, very low body weight and, in men, age. In overt hyperthyroidism, SHBG was 141.6 plus minus 37.6 nmol/l compared with 48.3 plus minus 16.2 nmol/l in controls in an older investigation (Földes 1990, PMID: 2392320). A high SHBG is therefore rarely the actual issue. It is usually a pointer to something else.
Do I need to fast for an SHBG test?
For SHBG itself there is no robust primary study I could cite on this. In practice blood is drawn fasting in the morning, but not because of SHBG. It is because of the values usually measured alongside it: guidelines place testosterone in a fasting morning sample (Bhasin 2018), and glucose and insulin need the fasting state anyway. Follow the instruction of the lab or the practice ordering the test. That instruction follows the whole panel, not one single value.
On which day of the menstrual cycle is SHBG measured?
SHBG is considerably more stable across the menstrual cycle than estradiol and progesterone, which can multiply within days. I did not find a well citable paper showing a relevant SHBG fluctuation across the cycle, so I give no number here. In practice that means: the cycle day of the blood draw follows the hormones measured alongside, not SHBG. Which day that is depends on the question being asked. The overview on this is in a separate article on hormone testing in women.
Is SHBG meaningful at all while on the pill?
As a mirror of your own metabolic situation, no. In a meta-analysis of 42 studies with 1495 healthy women, SHBG rose on average by 99.08 nmol/l under combined oral contraceptives, and free testosterone fell on average by 61 percent (Zimmerman 2014, DOI: 10.1093/humupd/dmt038). That is not a small shift, that is a different order of magnitude. The result then describes the pill. The international PCOS guideline explicitly regards androgen values under combined oral contraception as hardly reliable to interpret (Teede 2023, DOI: 10.1093/humrep/dead156). The value still says something for a different question: it shows that the liver responds to the estrogen.
How long after stopping the pill can SHBG be interpreted again?
The international PCOS guideline names a pause of at least three months with contraception otherwise secured, when an androgen assessment is strictly necessary (Teede 2023). What matters is the context of that sentence: it is a medical decision in a concrete situation, not a recommendation to stop the pill for the purpose of a lab test. Contraception, cycle complaints and skin all hang on it. Whether a pause makes sense for you is something you discuss with the physician who prescribed it. Whether SHBG settles permanently at a different level afterwards is not cleanly established.
How do you calculate free testosterone from SHBG?
Not in your head and not with a simple division. The established procedure derives the unbound fraction from total testosterone, SHBG and albumin using a binding model. Online calculators and lab software exist for this. In a method comparison, this calculated free testosterone was nearly congruent with the reference method equilibrium dialysis across very different SHBG conditions, with the exception of pregnancy (Vermeulen 1999, DOI: 10.1210/jcem.84.10.6079). What remains important: this is an estimate from a model, not a measurement. A large reappraisal concludes that the classical assumptions of the binding models are not supported by the published experimental data (Goldman 2017, DOI: 10.1210/er.2017-00025). The number is good enough for the direction. It is not good enough for a self diagnosis.
What is the free androgen index and where are its limits?
The free androgen index, FAI for short, puts total testosterone in relation to SHBG. It is no more calculation than that, and precisely that is its problem: albumin does not appear in it, although it is the second binding partner in the blood. In the method comparison, the ratio of FAI to the reference value varied with the level of SHBG, and the authors concluded that FAI is not a reliable index of bioavailable testosterone (Vermeulen 1999). The international PCOS guideline nonetheless explicitly permits the calculated FAI as an estimate of free testosterone (Teede 2023). Both statements hold: practically usable, methodologically the cruder of the two calculations, unreliable at the edges.
Is a low SHBG the same as diabetes?
No. SHBG is not a diagnostic criterion for diabetes, not for metabolic syndrome and not for polycystic ovary syndrome either. What the data show is a statistical association in groups. In the Women's Health Study the odds ratios for newly occurring type 2 diabetes across the SHBG quartiles lay clearly below one, and a Mendelian randomisation argued for a causal contribution (Ding 2009, DOI: 10.1056/NEJMoa0804381). Honesty requires adding: the effect estimates are very large, the case numbers small, and the authors themselves write that the clinical usefulness still has to be tested. A lab value is not a fate.
Can SHBG be changed with supplements?
I found no robust evidence for this in my research, and therefore I name neither products nor doses nor sources of supply here. What actually shifted something in controlled studies was different: weight loss (Campbell 2012), a drug induced lowering of a raised insulin level (Nestler 1991, DOI: 10.1210/jcem-72-1-83) and thyroid status (Földes 1990). In a small randomised study SHBG also rose over 15 weeks of resistance training compared with a sedentary control group, although as a secondary endpoint in a small group (Ward 2020, DOI: 10.1038/s41598-020-76901-w).
Why are the reference ranges different in every lab?
Because SHBG is measured with different immunoassays that are not standardised against each other. Every lab sets its range using its own method and its own comparison group. On top of that, SHBG diverges strongly by sex, age, cycle phase, pregnancy and hormone use. That is why this article contains no reference table. What applies is the range printed next to the value on your own report, and comparison with a value from a different lab should be treated with caution. The most informative thing is the trend in the same lab with the same method.
Where SHBG connects to the rest of the system
SHBG does not stand on its own. It hangs on the liver, on insulin, on the thyroid, on contraception and on the question of how a person deals with an unclear result. These articles carry the threads further.
Hormone testing in women
Which test makes sense when and which cycle day counts for which value. The foundation on which SHBG becomes useful in the first place.
When a testosterone value is on your reportUnderstanding testosterone values
Time of day, measurement method, repetition. Why a single value is rarely enough and how you place it.
When your SHBG is lowInsulin resistance and hormones
What too much insulin does to the menstrual cycle, the ovary and the skin. The mechanism behind the strongest SHBG regulator.
When you want to know where SHBG is madeSugar, fructose and the liver
The liver is the building site. What happens there with sugar has a say in the production rate.
When SHBG is striking and the thyroid is openReading thyroid values correctly
Which values count and which can be skipped. Without the thyroid status an SHBG value is hard to interpret.
When you want to understand estrogen breakdownEstrogen and the liver
How the liver processes and breaks estrogen down, and why the same liver also produces the transport protein.
When your value was measured on the pillStopping the pill
What happens physically in the post pill phase, and why every decision about it belongs with medical supervision.
When cycle disturbance and androgenic signs come togetherUnderstanding polycystic ovary syndrome
The diagnosis follows its own criteria and belongs in medical hands. SHBG is a building block in it, not a criterion.
When weight and metabolism are the leverInsulin resistance and weight loss
The route by which SHBG moved most clearly in studies, and what is realistic about it.
When you want to know where environmental substances actXenoestrogens in everyday life
What is documented and what is not. At the transport protein they act barely at all according to the available laboratory work.
When you want to see the whole systemHormonal imbalance in women
The big overview of cycle, skin, mood and metabolism, from which this article goes deeper into one detail.
When the preoccupation with values becomes narrowUnderstanding eating disorders
Where caution tips into control, how you notice it and why that line matters for the hormonal situation itself.
If shakiness and cravings come with itBlood sugar and cortisol
The chain from blood sugar to cortisol to free hormones, and what reactive hypoglycaemia really means.
If a testosterone value is in questionTestosterone in women
Too much, too little, and why measuring in the low female range is so difficult.
If you want to understand the enginePCOS and insulin resistance
How insulin keeps androgens up and SHBG down, and what each measurement actually shows.
If exhaustion is the leading symptomCortisol and adrenal fatigue
What a single cortisol value cannot do, what marks out Cushing and Addison, and what remains of adrenal fatigue.
Scientific sources
- Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679. PMID: 37580037 · DOI: 10.1093/humrep/dead156 [Guideline] [Consensus Guideline]
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID: 29562364 · DOI: 10.1210/jc.2018-00229 [Guideline] [Consensus Guideline]
- Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod. 2011;85(3):431-441. PMID: 21613632 · DOI: 10.1095/biolreprod.111.092593 [Mechanism Review]
- Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications. Endocr Rev. 2017;38(4):302-324. PMID: 28673039 · DOI: 10.1210/er.2017-00025 [Mechanism Review]
- Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. PMID: 10523012 · DOI: 10.1210/jcem.84.10.6079 [Systematic Review]
- Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67(3):460-464. PMID: 2842359 · DOI: 10.1210/jcem-67-3-460 [In vitro]
- Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest. 2007;117(12):3979-3987. PMID: 17992261 · DOI: 10.1172/JCI32249 [In vivo, mouse] [In vitro]
- Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72(1):83-89. PMID: 1898744 · DOI: 10.1210/jcem-72-1-83 [human intervention study, no control group, n=6]
- Nestler JE, Singh R, Matt DW, Clore JN, Blackard WG. Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women. Am J Obstet Gynecol. 1990;163(4 Pt 1):1243-1246. PMID: 2220936 · DOI: 10.1016/0002-9378(90)90698-7 [human intervention study, n=5]
- Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288-1299. PMID: 16537739 · DOI: 10.1001/jama.295.11.1288 [Meta-analysis, k=43]
- Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009;361(12):1152-1163. PMID: 19657112 · DOI: 10.1056/NEJMoa0804381 [Cohort, case control with Mendelian randomisation]
- Luo X, Yang XM, Cai WY, Chang H, Ma HL, Peng Y, Wu XK. Decreased Sex Hormone-Binding Globulin Indicated Worse Biometric, Lipid, Liver, and Renal Function Parameters in Women with Polycystic Ovary Syndrome. Int J Endocrinol. 2020;2020:7580218. PMID: 33101409 · DOI: 10.1155/2020/7580218 [Cohort, n=1,000]
- Jaruvongvanich V, Sanguankeo A, Riangwiwat T, Upala S. Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. Ann Hepatol. 2017;16(3):382-394. PMID: 28425408 [Meta-analysis, k=16] The DOI listed in the dataset does not resolve, so only the PMID is given here.
- Zimmerman Y, Eijkemans MJC, Coelingh Bennink HJT, Blankenstein MA, Fauser BCJM. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(1):76-105. PMID: 24082040 · DOI: 10.1093/humupd/dmt038 [Meta-analysis, k=42, n=1,495]
- Földes J, Banos C, Lakatos P, Tarjan G. Serum sex hormone-binding globulin levels in thyroid diseases. Orv Hetil. 1990;131(29):1579-1582, Hungarian with English abstract. PMID: 2392320 [Cohort] No DOI is recorded in PubMed for this paper.
- Torre F, Calogero AE, Condorelli RA, Cannarella R, Aversa A, La Vignera S. Effects of oral contraceptives on thyroid function and vice versa. J Endocrinol Invest. 2020;43(9):1181-1188. PMID: 32219692 · DOI: 10.1007/s40618-020-01230-8 [Mechanism Review]
- Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724-731. PMID: 11158037 · DOI: 10.1210/jcem.86.2.7219 [Cohort, n=890]
- Campbell KL, Foster-Schubert KE, Alfano CM, Wang CC, Wang CY, Duggan CR et al. Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol. 2012;30(19):2314-2326. PMID: 22614972 · DOI: 10.1200/JCO.2011.37.9792 [RCT, n=439]
- Fabian CJ, Kimler BF, Donnelly JE, Sullivan DK, Klemp JR, Petroff BK et al. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with greater than 10 percent weight loss in postmenopausal women. Breast Cancer Res Treat. 2013;142(1):119-132. PMID: 24141897 · DOI: 10.1007/s10549-013-2730-8 [Cohort, n=24]
- Ward LJ, Nilsson S, Hammar M, Lindh-Astrand L, Berin E, Lindblom H et al. Resistance training decreases plasma levels of adipokines in postmenopausal women. Sci Rep. 2020;10(1):19837. PMID: 33199796 · DOI: 10.1038/s41598-020-76901-w [RCT, n=55]
- Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimaki T, Keildson S et al. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple loci implicated in sex steroid hormone regulation. PLoS Genet. 2012;8(7):e1002805. PMID: 22829776 · DOI: 10.1371/journal.pgen.1002805 [Cohort, GWAS, n=21,791]
- Chen Z, Tao S, Gao Y, Zhang J, Hu Y, Mo L et al. Genome-wide association study of sex hormones, gonadotropins and sex hormone-binding protein in Chinese men. J Med Genet. 2013;50(12):794-801. PMID: 24049095 · DOI: 10.1136/jmedgenet-2013-101705 [Cohort, GWAS, n=3,495]
- Milligan SR, Khan O, Nash M. Competitive binding of xenobiotic oestrogens to rat alpha-fetoprotein and to sex steroid binding proteins in human and rainbow trout plasma. Gen Comp Endocrinol. 1998;112(1):89-95. PMID: 9748407 · DOI: 10.1006/gcen.1998.7146 [In vitro]
- Bendridi N, Mappus E, Grenot C, Lejeune H, Cuilleron CY, Pugeat M. Intravenous injection of human sex steroid hormone-binding globulin in mouse decreases blood clearance rate and testicular accumulation of orally administered iodobisphenol A. Steroids. 2002;67(7):637-645. PMID: 11996937 · DOI: 10.1016/s0039-128x(02)00014-4 [In vivo, mouse]
- The free hormone hypothesis is a model. The reappraisal in Endocrine Reviews concludes that the classical assumptions about stoichiometry and binding dynamics are not supported by the published experimental data. Everything in this article about free fractions stands under that reservation.
- The insulin chain is documented across three levels, but the human level is tiny. Six women in the positive study, five in the negative one, both without a control group, with the prescription only active substance diazoxide, which was used here outside its authorisation and with a deterioration of glucose tolerance, and which is no longer used this way today. That is a pointer to a mechanism and not a statement about therapy.
- The mechanism via HNF-4alpha comes from cell culture and transgenic mice. It explains the observations in humans well, but it has not itself been shown in humans.
- The male data in the 2009 paper come from a cohort of their own. The women come from the Women's Health Study, the men from the independent Physicians' Health Study II. So it was not a women's cohort that was also analysed for men.
- The odds ratios from the Mendelian randomisation are extremely large. With small case numbers such effect estimates are as a rule upper bounds. The authors explicitly name the clinical usefulness as still to be tested.
- The pooled testosterone value of the fatty liver meta-analysis has an I squared of 99 percent. The individual studies differ extremely. The pooled value shows a direction, not a robust number.
- There is no good citable paper on the cycle dependence of SHBG. That is why no number appears here, only the cautious statement that SHBG is more stable than the steroid hormones.
- On the fasting question I found no primary source. The usual fasting blood draw is justified here by the values measured alongside, not by SHBG itself.
- What happens to SHBG after stopping the pill has not been cleanly investigated. The guideline names three months as a condition for a reliable androgen assessment. Whether a residual state remains I leave open, because I found no robust study on it.
- Growth hormone, corticosteroid preparations, underweight and prolonged fasting stand here as textbook knowledge. They appear in every lab catalogue, but in this round I did not cross verify a primary paper with robust numbers for them. Hence without numbers and without a study citation.
- There is no robust evidence for changing SHBG with supplements. That is why this article contains no products, no doses and no sources of supply.
- The evidence labels deliberately separate several levels. A meta-analysis of observational studies and a guideline do not carry the same label here as a randomised trial. Observational data show associations, not causes, and a guideline is a consensus and not an investigation of its own.
- The resistance training study had SHBG as a secondary endpoint, a small group, no dietary control and good training adherence in only part of the group. It supports a hypothesis, not a recommendation.
- The weight studies come from postmenopausal women with overweight. Whether the same percentages apply to younger women, to women of normal weight or to men is not shown by them.
- The environmental link is deliberately stated weakly at this point. In vitro, xenoestrogens displaced the body's own steroids from the transport protein only at grossly excessive concentrations, and the mouse experiment on bisphenol A is a mouse experiment. An indirect route via liver and insulin situation is plausible, but not documented for SHBG. Anything beyond that would be speculation.
- What deliberately does not appear here. No reference table, because reference ranges depend on the method. No formula to calculate with, because no treatment follows from a self calculated number. No dose, no product, no test provider. And no advice to change, reduce or stop the pill, a thyroid preparation, metformin, an antiandrogen or a hormone therapy on your own. Every adjustment belongs with medical supervision. From no section of this article does it follow that a gynaecological workup or a recommended procedure should be postponed or replaced. What I describe from my consultations is marked as observation and is not a study result.